Legend Biotech
Legend Biotech Corporation, a prominent player in the biotechnology industry, is headquartered in the United States. Founded in 2014, the company has rapidly established itself as a leader in cell therapy, particularly in the development of innovative treatments for cancer. With a focus on CAR-T cell therapies, Legend Biotech's flagship product, cilta-cel, has garnered significant attention for its unique approach to targeting multiple myeloma. Operating primarily in the US and expanding its reach globally, Legend Biotech has achieved notable milestones, including strategic partnerships and advancements in clinical trials. The company is recognised for its commitment to advancing personalised medicine, positioning itself at the forefront of the biopharmaceutical landscape. With a robust pipeline and a dedication to transformative therapies, Legend Biotech continues to make significant strides in improving patient outcomes.
DitchCarbon Score
How does Legend Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Legend Biotech's score of 54 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Legend Biotech's reported carbon emissions
In 2024, Legend Biotech reported total emissions of approximately 12,420,000 kg CO2e, comprising 769,000 kg CO2e from Scope 1 and about 11,945,000 kg CO2e from Scope 2 (market-based). In 2023, the company recorded total emissions of around 12,973,530 kg CO2e, with 770,000 kg CO2e from Scope 1 and approximately 12,204,000 kg CO2e from Scope 2 (market-based). Despite these figures, Legend Biotech has not set specific reduction targets or initiatives as part of their climate commitments. The emissions data is cascaded from their parent company, Genscript Biotech Corporation, indicating a corporate family relationship that influences their sustainability reporting. Legend Biotech's headquarters is located in the US, and while they have disclosed emissions data for Scope 1 and Scope 2, there is currently no data available for Scope 3 emissions. The company continues to monitor and report its carbon footprint as part of its commitment to environmental sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 770,000 | 000,000 |
| Scope 2 | 12,204,000 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Legend Biotech is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
